Jacobo Mintzer to Aggression
This is a "connection" page, showing publications Jacobo Mintzer has written about Aggression.
Connection Strength
0.747
-
Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies. J Clin Psychiatry. 2006; 67 Suppl 10:3-5.
Score: 0.256
-
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry. 2016 May 01; 173(5):465-72.
Score: 0.128
-
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr. 2015 Dec; 27(12):2059-67.
Score: 0.125
-
Treatment of agitation in patients with dementia. Clin Geriatr Med. 1998 Feb; 14(1):147-75.
Score: 0.037
-
Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients. Psychiatr Serv. 1997 Nov; 48(11):1435-9.
Score: 0.036
-
Zolpidem for the treatment of agitation in elderly demented patients. J Clin Psychiatry. 1996 Aug; 57(8):372-3.
Score: 0.033
-
Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry. 1996; 57 Suppl 7:55-63; discussion 73-5.
Score: 0.032
-
Cross-cultural perspectives: agitation in demented patients in the United States. Int Psychogeriatr. 1996; 8 Suppl 3:487-90; discussion 491-2.
Score: 0.032
-
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29; 314(12):1242-54.
Score: 0.031
-
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012 Oct 18; 367(16):1497-507.
Score: 0.026
-
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb; 60(2):107-15.
Score: 0.010